D. E. Shaw & Co. Inc. acquired a new stake in Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 8,132 shares of the company's stock, valued at approximately $439,000. D. E. Shaw & Co. Inc. owned 0.09% of Semler Scientific as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also modified their holdings of the company. Principal Financial Group Inc. boosted its position in Semler Scientific by 633.1% during the 4th quarter. Principal Financial Group Inc. now owns 112,487 shares of the company's stock worth $6,074,000 after acquiring an additional 97,144 shares during the last quarter. IFP Advisors Inc acquired a new position in Semler Scientific during the 4th quarter worth approximately $54,000. Wells Fargo & Company MN boosted its position in Semler Scientific by 618.3% during the 4th quarter. Wells Fargo & Company MN now owns 103,465 shares of the company's stock worth $5,587,000 after acquiring an additional 89,060 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in Semler Scientific by 11.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 48,625 shares of the company's stock worth $2,626,000 after acquiring an additional 4,802 shares during the last quarter. Finally, Sanctuary Advisors LLC boosted its position in Semler Scientific by 13.2% during the 4th quarter. Sanctuary Advisors LLC now owns 5,012 shares of the company's stock worth $261,000 after acquiring an additional 584 shares during the last quarter. 49.37% of the stock is currently owned by institutional investors and hedge funds.
Semler Scientific Stock Performance
SMLR traded down $0.35 during trading hours on Friday, reaching $39.73. The company's stock had a trading volume of 698,780 shares, compared to its average volume of 490,834. Semler Scientific, Inc. has a 52 week low of $21.77 and a 52 week high of $81.56. The company's 50-day moving average is $36.10 and its 200-day moving average is $47.00. The firm has a market cap of $443.07 million, a PE ratio of 8.09 and a beta of 1.33.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported ($0.76) earnings per share for the quarter. The firm had revenue of $8.84 million for the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%.
Analysts Set New Price Targets
Separately, Wall Street Zen downgraded Semler Scientific from a "buy" rating to a "sell" rating in a research report on Thursday, May 22nd.
View Our Latest Analysis on Semler Scientific
Semler Scientific Profile
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Featured Articles
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
